123 related articles for article (PubMed ID: 6867608)
1. Prognostic value of serum lactic dehydrogenase in non-Hodgkin's lymphoma.
Hagberg H; Siegbahn A
Scand J Haematol; 1983 Jul; 31(1):49-56. PubMed ID: 6867608
[TBL] [Abstract][Full Text] [Related]
2. Serum lactate dehydrogenase (LDH) as a prognostic index for non-Hodgkin's lymphoma.
Endrizzi L; Fiorentino MV; Salvagno L; Segati R; Pappagallo GL; Fosser V
Eur J Cancer Clin Oncol; 1982 Oct; 18(10):945-9. PubMed ID: 6891644
[TBL] [Abstract][Full Text] [Related]
3. The use of serum deoxythymidine kinase as a prognostic marker, and in the monitoring of patients with non-Hodgkin's lymphoma.
Gronowitz JS; Hagberg H; Källander CF; Simonsson B
Br J Cancer; 1983 Apr; 47(4):487-95. PubMed ID: 6849793
[TBL] [Abstract][Full Text] [Related]
4. Serum lactate dehydrogenase isoenzyme pattern in non-Hodgkin's lymphomas.
Ricerca BM; Storti S; Campisi S; Pagano L; Dalla Torre F; Marra R; Amato A; Mango G; Bizzi B
Int J Biol Markers; 1988; 3(4):237-42. PubMed ID: 3235851
[TBL] [Abstract][Full Text] [Related]
5. Serum LDH concentration in non-Hodgkin's lymphomas. Relationship to histologic type, tumor mass, and presentation features.
Fasola G; Fanin R; Gherlinzoni F; Galieni P; Taruscio D; Frezza G; Mazza P; Pileri S; Baccarani M
Acta Haematol; 1984; 72(4):231-8. PubMed ID: 6438991
[TBL] [Abstract][Full Text] [Related]
6. Serum deoxythymidine kinase in small cell carcinoma of the lung. Relation to clinical features, prognosis, and other biochemical markers.
Gronowitz JS; Steinholtz L; Källander CF; Hagberg H; Bergh J
Cancer; 1986 Jul; 58(1):111-8. PubMed ID: 3011236
[TBL] [Abstract][Full Text] [Related]
7. Profiles and prognostic values of LDH isoenzymes in patients with non-Hodgkin's lymphoma.
Dumontet C; Drai J; Bienvenu J; Berard EN; Thieblemont C; Bouafia F; Bayle F; Moullet I; Salles G; Coiffier B
Leukemia; 1999 May; 13(5):811-7. PubMed ID: 10374888
[TBL] [Abstract][Full Text] [Related]
8. Serum lactic dehydrogenase as a prognostic tool for non-Hodgkin lymphomas.
Ferraris AM; Giuntini P; Gaetani GF
Blood; 1979 Oct; 54(4):928-32. PubMed ID: 476306
[TBL] [Abstract][Full Text] [Related]
9. Serum LDH values in childhood acute leukemias and non-Hodgkin's lymphoma.
Suarez CR; Andreeff M; Miller DR
Med Pediatr Oncol; 1984; 12(2):89-92. PubMed ID: 6583472
[TBL] [Abstract][Full Text] [Related]
10. [Prognostic parameters in patients with advanced non-Hodgkin's lymphoma].
Terblanche AP; Falkson G
S Afr Med J; 1986 Mar; 69(6):358-63. PubMed ID: 3961618
[TBL] [Abstract][Full Text] [Related]
11. A new serologic index for low-grade non-Hodgkin's lymphoma based on initial CA125 and LDH serum levels.
Benboubker L; Valat C; Linassier C; Cartron G; Delain M; Bout M; Fetissof F; Lefranq T; Lamagnere JP; Colombat P
Ann Oncol; 2000 Nov; 11(11):1485-91. PubMed ID: 11142490
[TBL] [Abstract][Full Text] [Related]
12. Lactate dehydrogenase levels in cellular extracts of human malignant lymphomas.
Vezzoni MA; Lucchini R; Giardini R; Raineri M; Murone M; Vezzoni P
Tumori; 1983 Aug; 69(4):279-82. PubMed ID: 6623651
[TBL] [Abstract][Full Text] [Related]
13. [Clinical significance of serum lactate dehydrogenase, β2-microglobulin and vascular endothelial growth factor level detection in patients with non-Hodgkin's lymphoma].
Duan Y; Li G; Hu HX
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Jun; 20(3):608-10. PubMed ID: 22739165
[TBL] [Abstract][Full Text] [Related]
14. [Significance of clinical and laboratory chemical parameters for the course and prognosis of non-Hodgkin's lymphomas].
Steinke B; Mau J
Klin Wochenschr; 1986 May; 64(10):445-51. PubMed ID: 2425124
[TBL] [Abstract][Full Text] [Related]
15. Progress in the management of high risk non-Hodgkin's lymphomas. 10 years of experience of the 3rd Medical Department of Hanusch Hospital, Vienna.
Heinz R; Hanak H; Stacher A
Klin Wochenschr; 1985 Jul; 63(14):619-26. PubMed ID: 3839867
[TBL] [Abstract][Full Text] [Related]
16. Advanced diffuse non-Hodgkin's lymphoma. Analysis of prognostic factors by the international index and by lactic dehydrogenase in an intergroup study.
Gordon LI; Andersen J; Colgan J; Glick J; Resnick GD; O'Connell M; Cassileth PA
Cancer; 1995 Feb; 75(3):865-73. PubMed ID: 7530168
[TBL] [Abstract][Full Text] [Related]
17. Age and serum lactate dehydrogenase level are independent prognostic factors in human immunodeficiency virus-related non-Hodgkin's lymphomas: a single-institute study of 96 patients.
Vaccher E; Tirelli U; Spina M; Talamini R; Errante D; Simonelli C; Carbone A
J Clin Oncol; 1996 Aug; 14(8):2217-23. PubMed ID: 8708710
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of serum lactate dehydrogenase in malignant lymphoma.
Schneider RJ; Seibert K; Passe S; Little C; Gee T; Lee BJ; Miké V; Young CW
Cancer; 1980 Jul; 46(1):139-43. PubMed ID: 6992974
[TBL] [Abstract][Full Text] [Related]
19. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
[TBL] [Abstract][Full Text] [Related]
20. [Clinical analysis of rituximab combined with chemotherapy in treating aggressive B-cell non-Hodgkin's lymphoma].
Zhang HY; Lin TY; Jiang WQ; Zhang L; Huang HQ; Xia ZJ; Sun XF; He YJ; Guan ZZ
Ai Zheng; 2004 Dec; 23(12):1681-6. PubMed ID: 15601560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
